Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene.


Autoria(s): Tosic M.; Ott J.; Barral S.; Bovet P.; Deppen P.; Gheorghita F.; Matthey M.L.; Parnas J.; Preisig M.; Saraga M.; Solida A.; Timm S.; Wang A.G.; Werge T.; Cuénod M.; Do K.Q.
Data(s)

2006

Resumo

Oxidative stress could be involved in the pathophysiology of schizophrenia, a major psychiatric disorder. Glutathione (GSH), a redox regulator, is decreased in patients' cerebrospinal fluid and prefrontal cortex. The gene of the key GSH-synthesizing enzyme, glutamate cysteine ligase modifier (GCLM) subunit, is strongly associated with schizophrenia in two case-control studies and in one family study. GCLM gene expression is decreased in patients' fibroblasts. Thus, GSH metabolism dysfunction is proposed as one of the vulnerability factors for schizophrenia.

Identificador

http://serval.unil.ch/?id=serval:BIB_FC5ABE3EB470

isbn:0002-9297

pmid:16909399

doi:10.1086/507566

isiid:000239830700023

Idioma(s)

en

Fonte

American journal of human genetics, vol. 79, no. 3, pp. 586-92

Palavras-Chave #Case-Control Studies; Down-Regulation; Fibroblasts; Gene Frequency; Genetic Predisposition to Disease; Glutamate-Cysteine Ligase; Glutathione; Humans; Oxidative Stress; Polymorphism, Single Nucleotide; RNA, Messenger; Schizophrenia
Tipo

info:eu-repo/semantics/article

article